Categories
Articles

Changshang Chang


Changshang
Chang

 

1. The Introduction of the Taiwanese Osteoporosis Society
President’s Award for Dr. Chawnshang Chang
(click for detailed
information)

2. Education:

  1. National
    Taiwan University, Agriculture Chemistry, BS, 1978

  2. Taiwan
    Army Chemical School (ROTC), Taiwan, Chemistry, Lieutenant, 1980

  3. University
    of Chicago, Chicago, Illinois, Biochemistry and Molecular Biology, Ph.D.,
    1985

  4. University
    of Chicago, Chicago, Illinois, Molecular Endocrinology Postdoc, 1988

3. Professional and Academic
Experience:

  1. 1988-90
    Assistant Professor and Director, Urology Research Labs, Dept. of
    Surgery/Urology and Ben May Institute, University of Chicago, Chicago, IL

  2. 1990-00
    Assistant Professor (90-93), Associate Professor (93-96), Professor
    (96-97). Visiting Professor (97-00), Director, Tissue & Blood Bank
    (90-97). Departments of Human Oncology and Medicine and UW Comprehensive
    Cancer Center, University of Wisconsin, Madison, WI

  3. 1996-98
    Visiting Professor, Department of Urology, Osaka University, Osaka, Japan

  4. 1998-
    Visiting Professor, Oncology Institute, Xiamen University, Xiamen, China

  5. 1998-
    Visiting Professor & Director of Andrology Lab, Dept. of Urology,
    Beijing Medical Univ., China

  6. 1999-
    Director and Adjunct Professor, Reproductive Medicine Institute, Chang
    Gung University, Taiwan

  7. 1999-
    Director and Adjunct Professor, Steroid Hormone Research Center, National
    Taiwan Univ., Taiwan

  8. 1997-
    Director, George Whipple Laboratory for Cancer Research, University of
    Rochester, Rochester, NY

  9. 1997-
    Director, Urology Research Center, University of Rochester, Rochester, NY

  10. 1997-
    Director, Molecular Oncology Graduate Program. University of Rochester,
    Rochester, NY

  11. 1997-
    George Whipple Distinguished Professor, Departments of Pathology, Urology,
    Radiation Oncology and Biochemistry, and The Cancer Center, University of
    Rochester, Rochester, NY

4. Honors and Awards:

  1. 1988
    The Ayerst Award for Outstanding Young Endocrinologist from the Endocrine
    Society

  2. 1989
    Andrew Melon Award for Outstanding Young Faculty in USA from Andrew Melon
    Foundation

  3. 1990
    Outstanding Young Investigator Award from Cancer Research Foundation

  4. 1991
    The Milheim Award for Excellence in Cancer Research from Milheim
    Foundation

  5. 1991-94
    American Cancer Society Junior Professorship in Cancer Research

  6. 1995-97
    Blowity-Ridgeway Award in Andrology from Blowity-Ridgeway Foundation

  7. 1993-99
    CapCure Award (6 times) for Excellence in Prostate Cancer Research

  8. 1997
    Award with Honorary Fellow from The Japan Society of Andrology (The 2nd
    Non-Japanese ever awarded such honor)

  9. 1998
    George Hoyt Whipple Lecture, University of Rochester, Rochester, NY

  10. 1998
    Jiepimg Wu Award, for Outstanding Achievement in Urology (The highest
    honor for Chinese-Medical Researcher). Beijing, China.

  11. 1999
    President Award for Outstanding Urology Research, The highest honor from
    The Urology Association of Taiwan for the Contribution in Androgen
    Receptor and Prostate Cancer.

  12. 1999
    Davey Memorial Award for Outstanding Cancer research, University of
    Rochester.

  13. 1999
    Scholar of the Year, The highest honor from The Taiwanese Osteoporosis
    Association for Outstanding Contribution in Sex hormones and Osteoporosis.

  14. The Taiwanese Osteoporosis Society President’s Award

5. Grant and Publication Review:

  1. 1995-
    Associate Editor, Frontiers in Bioscience.

  2. 1999-
    Member of Editorial Board, Endocrine.

  3. 1999-
    Member of Editorial Board, The Prostate Journal

  4. 1994-01
    NIH Study Section: Ad Hoc & Regular Member at Biochemical
    Endocrinology

  5. 1992-96
    VA Merit Grant Oncology Study Section

  6. 1993-95
    NIH Prostate SPORE P50 Center Grant; and NIH PO1 Core Grant

  7. 1993-
    ARMY Breast Cancer Grant Pathology Study Section

  8. 1992-98
    Medical Research Council of Canada and Dutch Cancer Society Grant;

  9. 1998-
    NIH Research Centers in Minority Institutes Core Grant 1996-99 Taiwan CRC
    Biomedical Sciences Project and Taiwan National Science Council Grant

  10. 1990-
    Reviewer in PNAS/JBC/Mol. Endo/Cancer Research and 16 other peer-reviewed
    journals Invited Speaker: 47 International Symposia and 188
    Universities/Institutes (1988-present)

6. Research Projects Ongoing or
Completed During the Last 3 Years:

        
Title I: “TR2
and TR3 Orphan Receptors in Prostate Cancer” (15% effort) -Agency:
NIH/NIDDK; RO1-DK47258, Years 5-8 (09/01/99-08/31/03). P.I.: Chawnshang Chang,
Ph.D. The goals of this project are to study the up- and down-stream regulation
of TR2/TR3 in prostate.

        
Title II: “TR4
Orphan Receptor in Testis” (15% effort) -Agency: NIH/NIDDK; RO1-DK56984,
Years 1-4 (01/01/01-12/31/04). P.I.: Chawnshang Chang, Ph.D. The goals of this
project are to study the associated proteins that may modulate TR4 function.

        
Title III:
“PTEN Tumor Suppressor in Breast Cancer” (10% effort) Agency:
ARMY/Breast Program; Idea Award, Years 1-3 (06/01/01?5/31/04). P.I.: Chawnshang
Chang, Ph.D. The goals of this project are to study the role of PTEN in breast
cancer.

        
Title IV:
“Suppression of AR Transactivation by AKT Kinase” (10% effort)
Agency: ARMY/Prostate Program; Idea Award, Years 1-3 (01/01/02?2/31/04). P.I.:
C. Chang, Ph.D. The goals of this project are to study the mechanism of Akt
signal pathway.

        
Title V
“Induction of AR Transactivation by DHT vs E2” (15% effort) -Agency:
NIH/NIDDK; RO1-DK60905, Years 1-4 (09/30/01-08/31/05). P.I.: Chawnshang Chang,
Ph.D. The goal of this project is to dissect the differences between E2 and DHT
for AR transactivation.